1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Nephro Care India Limited

Nephro Care India Limited

NNSE:NEPHROCARE
83.00
INR
-2.95
(-3.43%)
0.87EPS
59.28P/E
853.17MMarket Cap
Nephro Care India Limited
NSE:NEPHROCARE
(National Stock Exchange of India)

Recent

price

83.00

P/E

ratio

59.28

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
2026
TTM
INR
1.11
2.08
10.37
16.52
30.12
51.38
26.59
Revenue per Share
0.05
-0.01
1.18
2.68
2.38
2.04
0.87
Basic EPS, GAAP
0.09
-1.38
2.28
-1.44
-14.38
-3.39
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.3
1.48
9.11
32.44
34.49
34.49
Book Value per Share
0.01
0.3
1.48
9.11
32.43
34.42
34.42
Tangible Book Value per Share
16
16
16
16
15
16
16
Basic Weighted Avg Shares
18
34
171
272
460
847
434
Sales/Revenue/Turnover
7.76
0.41
16.89
21.81
7.41
-1.95
-6.94
Operating Margin (%)
- -
1
8
5
25
51
30
Depreciation Expense
1
- -
19
44
36
34
14
Net Income, GAAP
24.77
5,000
28.35
27.65
24.65
27.97
23.34
Effective Tax Rate (%)
4.86
-0.29
11.36
16.2
7.91
3.98
3.28
Profit Margin (%)
- -
-6
-5
50
142
155
155
Working Capital
6
25
24
- -
- -
- -
- -
LT Debt
- -
5
24
150
535
569
569
Total Equity
- -
-36.81
46.1
37.96
7.38
-2.14
-4.11
Return on Invested Capital (%)
- -
-39.3
50.61
44.3
10.65
6.31
2.58
Return on Capital (%)
- -
-3.84
132.46
50.52
10.62
6.11
2.54
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
2,355
1,789
853

Working Capital

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
259
- -
308
Cash, Cash Equivalents & STI
141
- -
165
Accounts Receivable, Net
46
- -
60
Inventories
22
- -
23
Total Current Liabilities
106
- -
153
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
874.47%
6.39%
Free Cash Flow
- -
-247.49%
-74.54%
Net Income, GAAP
- -
-3,985.86%
-7.42%
Sales/Revenue/Turnover
- -
139.84%
84.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
75
272
2025
- -
- -
- -
- -
460
2026
- -
- -
227
207
847

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.61
2.68
2025
- -
- -
- -
- -
2.38
2026
- -
- -
0.26
0.61
2.04

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Nephro Care India Ltd. operates within the healthcare sector, concentrating on comprehensive services for kidney-related conditions. Established in 2014 by Dr. Pratim Sengupta, the company is headquartered in Kolkata, India, and offers a full spectrum of renal insufficiency treatments. Its services encompass hemodialysis, peritoneal dialysis, kidney transplant care, conservative nephrology, and associated diagnostic and support offerings. The company emphasizes a 360-degree holistic care approach, integrating medical, lifestyle, and nutritional support for patients. Nephro Care India has expanded its reach, having recently completed an Initial Public Offering (IPO) in July 2024 and listed on the NSE Emerge platform. The firm is actively growing its infrastructure, with plans to establish additional comprehensive kidney care centers across India and has inaugurated a 100-bedded multi-specialty hospital in Kolkata.